Market header image

Filings

You are here

Home › Trading › Market Activity › Company Filings › Curaleaf - Restated Q3 2022 interim MD&A in US GAAP

Curaleaf - Restated Q3 2022 interim MD&A in US GAAP

May 1, 2023


CSE Listing(s):

AttachmentSize
PDF icon CURA_MDA_Q3_2022_USGAPP.pdf713.01 KB

Search form